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AbstrACt
Objective Men who have sex with men (MSM) remain 
vulnerable to sexually transmitted infections (STIs) and are 
advised to be tested at least twice a year. The aim of this 
study was to assess the determinants of test frequency 
and their associations with an STI diagnosis.
Design A 6-year retrospective study.
setting 5 STI clinics in the eastern part of the 
Netherlands.
Participants MSM whose mean test interval was 6 
months or more were grouped as ‘infrequently tested’ 
(n=953), and those with a mean test interval less than 6 
months were grouped as ‘frequently tested’ (n=658).
Primary and secondary outcome measures Test 
frequency and STI diagnosis and determinants.
results MSM who were ever diagnosed with an STI 
(OR=1.4, 95% CI 1.1 to 1.7), MSM who had never had STI 
symptoms (OR=0.8, 95% CI 0.6 to 1.0), and MSM who had 
ever had sex with both men and women (OR=0.6, 95% CI 
0.5 to 0.8) were more often frequently tested. Moreover, in 
both groups, MSM who had ever been notified by a partner 
(OR=2.2, 95% CI 1.7 to 2.9 infrequently tested; OR=2.0, 
95% CI 1.4 to 2.9 frequently tested), MSM who had ever 
had STI symptoms (OR=1.6, 95% CI 1.2 to 2.1 infrequently 
tested; OR=1.8, 95% CI 1.3 to 2.6 frequently tested) and 
MSM who were ever diagnosed with HIV (OR=2.7, 95% CI 
1.5 to 4.6 infrequently tested; OR=6.8, 95% CI 2.6 to 17.5 
frequently tested) were more likely to be diagnosed with 
an STI.
Conclusions Among MSM visiting STI clinics, those who 
were ever diagnosed with HIV were more often diagnosed 
with an STI, but did not visit STI clinics more frequently 
than HIV-negative MSM. This highlights the necessity of 
encouraging MSM who are diagnosed with HIV to have STI 
tests more frequently.
IntrODuCtIOn
Men who have sex with men (MSM) 
contribute to the worldwide burden of 
sexually transmitted infections (STIs), 
including HIV.1–3 Some studies have found 
that MSM reported large proportions of diag-
noses of HIV (42%), gonorrhoea (43%) and 
syphilis (58%).4 5 In the Netherlands, MSM 
accounted for the greatest contribution to 
STI diagnoses in 2016 at STI clinics; 21% of 
the tests were positive for one or more STIs.6 
Early detection and treatment are crucial 
to reduce the risk of STI transmissions 
(including HIV) among MSM.7 Therefore, 
test frequency is important in reducing 
STI transmissions. In Australia, MSM are 
advised to get a test at least once a year, but 
one study reports that this advice is poorly 
adhered to: the retesting rate at 1 year was 
35%.8 A British study estimates that 55% 
of the MSM were tested once a year, where 
strengths and limitations of this study
 ► Longitudinal data of men who have sex with men 
(MSM) with at least three consultations at regional 
Dutch sexually transmitted infection (STI) clinics be-
tween 2008 and 2013 were analysed.
 ► The current study has a long follow-up of 5 years, so 
a large number of MSM were included in analyses.
 ► The MSM population in the eastern part of the 
Netherlands and their test behaviour may differ from 
the rest of the country.
 ► STI diagnosis was only available for those who came 
back for repeat testing; they do not represent the 
reinfections contracted by all MSM who visit STI 
clinics.
 ► Only STI  clinic consultations were available; data 
from STI tests carried out by general practitioners 
or other specialists could not be taken into account.
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guidelines also recommend HIV tests once a year (and 
more often for those at ‘higher risk’).9
There were only informal guidelines for test frequency 
among MSM in the Netherlands before 2017, based on 
expert opinion. These informal guidelines recommended 
STI testing for MSM at least twice a year. A formal guide-
line, based on Dutch epidemiological findings, has now 
(2017) been drafted, and it advises MSM to be tested at 
least twice a year, and high-risk MSM (eg, MSM who were 
diagnosed with HIV or MSM who are commercial sex 
workers) four times a year. However, the annual testing 
uptake among MSM in the Netherlands is low. One Dutch 
study on STI consultations in Amsterdam from 2009 to 
2013 reports that 35% of the HIV-negative MSM returned 
to the STI clinic within 1 year after their initial consulta-
tion.10 Another Dutch study based on national STI clinic 
data from 2014 to 2015 reports that 48% of the MSM 
were tested more than once during a 1.5-year follow-up. 
Only 19% of the MSM were tested consistently every 6 
months.11
No studies have yet simultaneously investigated the 
relation between MSM test frequency and STI diagnosis, 
with the determinants, in the Netherlands. The aim of 
this study was to assess the determinants of test frequency 
and of STI diagnosis among MSM visiting STI clinics in 
the eastern part of the Netherlands. The results of the 
study could provide more insight into the frequency 
and relevance of testing according to the guidelines for 
certain MSM risk groups.
MethODs
study setting and design
In the Netherlands, general practitioners and STI clinics 
based in regional public health services (RPHSs) provide 
primary STI care. The STI clinics are freely accessible and 
government-funded; they aim to reach high-risk groups 
who might otherwise not seek timely STI care. The STI 
clinic at the RPHS is always accessible to MSM, whether 
or not reporting STI-related symptoms, while there is a 
triage system for heterosexuals. Furthermore, MSM are 
always tested for five STIs: chlamydia, gonorrhoea, syph-
ilis, HIV (unless clients opt out) and hepatitis B (when 
not successfully vaccinated against hepatitis B).6
We performed a 6-year retrospective study (2008–2013) 
using data from 5 of the 25 Dutch STI clinics. The partici-
pating clinics were in the east of the Netherlands, which is 
a semirural area. All of them used an online patient regis-
tration system in which sexual preference was a manda-
tory question. Data from 2013 onwards were not included 
due to changes in the patient registration system of the 
STI clinics. The definitions of database variables could 
not be matched.
study population
We selected all men who reported having sex with men or 
sex with both women and men, and men who identified 
themselves as homosexual or bisexual (hereafter referred 
to as MSM). Only MSM who had three or more consulta-
tions were included in the study because three or more 
consultations were considered to approximate an actual 
test frequency. We selected MSM who had a minimum 
of 18 months of follow-up after the first consultation 
(which took place before June 2012, with a follow-up time 
extending into 2013) because all MSM had to have suffi-
cient time to return for two retests. Furthermore, consul-
tations within 35 days of a previous visit were excluded 
to ensure that no possible test-of-cure consultations were 
included.
Data description
For each consultation, the following variables were used: 
age (<26 years and ≥26 years—clients younger than 26 
years are considered ‘young’ as decided by the national 
STI clinic regulations); ethnicity (due to a change in 
registration, ethnicity was a combination of variables 
that consisted of self-defined ethnicity (from 2006 until 
2010) and ethnicity based on (parental) country of birth 
(from 2011 until 2013); MSM were subsequently cate-
gorised into Dutch, other Western and non-Western); 
having been notified by a partner; having STI symptoms; 
socioeconomic status (SES, based on postal codes (four 
digits))—this measure of SES was deduced by postal 
code-associated data from the Netherlands Institute 
for Social Research and is a measure composed of four 
variables: average income per household, percentage of 
households with low income, percentage of residents 
without a paid job and percentage of households with 
an average to low education; number of sexual partners 
in the last 6 months; being diagnosed with an STI during 
the study period; and sexual preference (reported 
as having sex with men or sex with men and women). 
HIV status was considered a separate variable based on 
existing literature that indicates that MSM who are diag-
nosed with HIV are more likely to be diagnosed with an 
STI.12–15 MSM were defined as diagnosed with HIV when 
they were diagnosed with HIV during the study period 
or were already diagnosed with HIV before the study 
period.
Data analysis
The determinants age, ethnicity and SES were taken 
from the first consultation in all analyses because these 
determinants are reasonably stable over time. The mean 
number of partners reported per consultation was used 
to  determine the number of partners in the analysis. 
All other determinants were assessed on the basis of the 
occurrence of the event within all individual consulta-
tions, which resulted in an ‘ever’ and ‘never’ occurring 
categorisation.
The outcome test frequency was defined as follows: 
MSM were defined infrequently tested if their mean test 
intervals were 6 months or more. They were defined 
as frequently tested if their mean test intervals were 
less than 6 months. A 1-month margin was taken into 
account to ensure that a person would not be regarded 
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as infrequently tested if the mean test interval was only 
slightly more than 6 months.
The outcome STI diagnosis was defined as follows: any 
one of the MSM was defined as being diagnosed with one 
or more STIs, including chlamydia, gonorrhoea, syphilis 
and/or infectious hepatitis B, in one or more body loca-
tions (oral, genital or anal) at one or more consultations 
during the study period.
If more than 5% of the values were missing for a vari-
able, these missing values were included in the analysis in 
a separate category to reduce loss of data. We performed 
logistic regression analyses to identify determinants of 
testing frequency and STI diagnosis. Collinearity between 
variables was checked beforehand. We used the Enter 
method with multivariable logistic regression to further 
analyse determinants with a p value less than 0.20 in 
univariable analyses. The multivariable logistic regression 
was corrected for the number of consultations because 
the reporting of an event (eg, ever having STI symptoms) 
is more likely when MSM visit the STI clinic more often. 
In all analyses, determinants with p<0.05 were considered 
statistically significant. We present ORs and 95% CIs to 
show the associations between the determinants and the 
outcomes in tables 1 and 2. We used IBM SPSS V.22 soft-
ware for the analyses.
Patient and public involvement
The study used routinely collected anonymous surveil-
lance data. Hence, STI clinic visitors were not directly 
involved in the development or execution of this study, 
and neither could the results be disseminated to them.
results
study population and test frequency
A total of 5954 MSM visited one of the five participating 
STI clinics between 2008 and 2013. A total of 1913 MSM 
had three or more consultations, of whom 1611 also had 
a minimal follow-up time of 18 months after the first 
consultation and thus were included. The group ‘infre-
quently tested’ consisted of 953 MSM (59.2%), and the 
group ‘frequently tested’ consisted of 658 MSM (40.8%).
Table 1 shows that among the infrequently tested 
MSM, 47.0% were ever diagnosed with an STI, compared 
with 64.6% of the frequently tested MSM. Table 1 also 
compares the characteristics of the two groups. Multivari-
able analysis showed that the frequently tested had more 
often been diagnosed with an STI (OR 1.4, 95% CI 1.1 
to 1.7), were less likely to ever have reported STI-related 
symptoms (OR 0.8, 95% CI 0.6 to 1.0) and had less often 
ever had sex with men only (OR 0.6, 95% CI 0.5 to 0.8) 
than the infrequently tested.
stI diagnosis
Table 2 shows the determinants of having an STI diag-
nosis. The same determinants of STI diagnosis were iden-
tified in both groups: MSM who had ever been notified by 
a partner, MSM who had ever had STI-related symptoms 
and MSM who were ever diagnosed with HIV were more 
likely to have an STI diagnosis. In addition, frequently 
tested MSM who only had sex with men were more likely 
to have an STI diagnosis, which was not seen among infre-
quently tested MSM.
DIsCussIOn
In this study, we found that 59.2% of the included MSM 
were infrequently tested (mean test interval ≥6 months) 
and 40.8% were frequently tested (mean test interval <6 
months). MSM who were ever diagnosed with an STI, 
MSM who had never had STI symptoms, and MSM who 
had ever had sex with men as well as women were more 
often frequently tested. Moreover, we found that the 
determinants for STI diagnosis were the same in both 
groups. MSM who had ever been notified by a partner, 
MSM who had ever had STI symptoms and MSM who 
were ever diagnosed with HIV were more likely to be diag-
nosed with an STI.
This is the first study in the Netherlands that addresses 
both test frequency and STI diagnosis among MSM 
who were and were not diagnosed with HIV. Further-
more, our study has a long follow-up of 5 years, so a large 
number of MSM were included in analyses. However, the 
study has several limitations. First, it took place in the 
eastern part of the Netherlands, which is a semirural area. 
The study population and their test behaviour may differ 
from the rest of the Netherlands. Second, STI diagnosis 
was only available for those who came back for repeat 
testing; they do not represent the reinfections contracted 
by all MSM who visit STI clinics. Third, in this study, only 
STI clinic consultations were available, so data from STI 
tests carried out by general practitioners or other special-
ists could not be taken into account. The number of 
STI consultations per individual might therefore be an 
underestimation, and MSM could have been categorised 
differently if consultations from other caregivers have 
been included. Fourth, due to changes in the patient 
registration system, we could not include data beyond the 
year 2013. The STI clinic has, however, always been freely 
accessible to MSM over the years. We do not think there 
have been any sudden changes in risk behaviour and/or 
test frequency among MSM; therefore, we think the data 
of the current study are still of importance to STI care 
nowadays. Fifth, we excluded MSM with only one consul-
tation. We reasoned that leaving them out would provide 
us with a more valid overview of test frequency in those 
who appear to be a regular client of STI clinics.
With the study methods we chose, this study shows that, 
of all the MSM with at least three consultations, 41% 
were frequently tested and they had a mean test interval 
of less than 6 months. The methods of the current study 
differ widely from other comparable Dutch studies so 
comparison is difficult.10 11 Vriend and colleagues’10 
study found that 16% of HIV-negative MSM returned 
for repeat tests within 6 months. We only included MSM 
with at least two subsequent tests and a minimum of 18 
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months of follow-up, whereas Vriend and colleagues10 
also included MSM only tested once in their analyses, 
which made the comparison of the proportions of the 
frequently tested group in their study and our study 
difficult. However, Vriend and colleagues also looked at 
a consistent 12-month testing among people with at least 
3 years of follow-up (ie, three or more tests) and found an 
uptake of 36%, which is more in line with our study.
Our results show that MSM who had ever been diag-
nosed with an STI are more often frequently tested. 
Table 1 Characteristics of the frequently and infrequently tested groups and the determinants of test frequency for MSM who 
visited an STI clinic in the eastern part of the Netherlands, 2008–2013
Infrequently tested 
(n=953)
n (%)
Frequently tested 
(n=658)
n (%)
Frequently versus infrequently tested
Univariable analyses
OR (95% CI)
Multivariable 
analysis
OR (95% CI)
Median number of consultations (IQR) 4  (3–5) 6 (4–9)
Age (in years at baseline)
  <26 242 (25.4) 140 (21.3) Ref Ref
  ≥26 711 (74.6) 518 (78.7) 1.3 (1.0 to 1.6) 0.9 (0.7 to 1.2)
Ethnicity (baseline)
  Dutch 857 (89.9) 584 (88.8) Ref NT
  Non-Western 62 (6.5) 47 (7.1) 1.1 (0.8 to 1.6)
  Other Western 34 (3.6) 27 (4.1) 1.2 (0.7 to 2.0)
Socioeconomic status (baseline)
  Low 281 (29.5) 183 (27.8) 1.0 (0.7 to 1.2) NT
  Intermediate 349 (36.6) 256 (38.9) 1.1 (0.9 to 1.4)
  High 300 (31.5) 203 (30.9) Ref
  Missing 23 (2.4) 16 (2.4)
Mean number of partners
  <2 122 (12.9) 67 (10.3) Ref Ref
  2–5 406 (43.0) 227 (35.0) 1.0 (0.7 to 1.4) 1.0 (0.7 to 1.5)
  ≥5 416 (44.1) 354 (54.6) 1.6 (1.1 to 2.2) 1.2 (0.8 to 1.8)
  Missing 9 (0.0) 10 (0.0)
Notified by a partner
  Never 511 (53.6) 267 (40.6) Ref Ref
  Ever 442 (46.4) 391 (59.4) 1.7 (1.4 to 2.1) 1.1 (0.9 to 1.4)
Diagnosed with an STI
  Never 505 (53.0) 233 (35.4) Ref Ref
  Ever 448 (47.0) 425 (64.6) 2.1 (1.7 to 2.6) 1.4 (1.1 to 1.7)
STI-related symptoms
  Never 454 (47.6) 273 (41.5) Ref Ref
  Ever 499 (52.4) 385 (58.5) 1.3 (1.1 to 1.6) 0.8 (0.6 to 1.0)
Sexual preference
  Sex with men and women 232 (24.3) 212 (32.2) Ref Ref
  Sex with men only 714 (74.9) 442 (67.2) 0.7 (0.5 to 0.8) 0.6 (0.5 to 0.8)
  Unknown 7 (0.7) 4 (0.6)
Diagnosed with HIV
  Never 860 (90.2) 568 (86.3) Ref Ref
  Ever 93 (9.8) 90 (13.7) 1.5 (1.1 to 2.0) 0.8 (0.5 to 1.2)
Values in bold were significant (p<0.05); due to rounding into 1 decimal, 1.0 is not always significant.
Regression analysis corrected for the number of consultations.
MSM, men who have sex with men; NT, not tested in multivariable model, since p>0.20 in univariate analysis; ref, reference; STI, sexually 
transmitted infection.
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However, MSM who had ever been notified by a partner 
and MSM who had ever had STI-related symptoms are not 
more likely to be frequently tested. This is in line with 
another study which finds that MSM who have been noti-
fied by a partner or who have reported STI symptoms 
return to the STI clinic sooner, but are not more likely 
to be consistently tested every 6 months.11 Furthermore, 
our study shows that MSM who had ever had sex with 
men as well as women were more often frequently tested. 
In two other Dutch studies, men who had sex with both 
genders less often had repeat tests.10 11 We do not have 
a clear explanation for this discrepancy, but a reporting 
bias in sexual preference could be a possible explanation. 
Further research is needed to gain more insight into this.
Regarding STI diagnosis, we show that MSM who had 
ever been notified by a partner, MSM who had ever had 
STI symptoms and MSM who were ever diagnosed with 
HIV were more likely to have an STI diagnosis. These 
results are in line with other studies.12–16 A British anal-
ysis using multiple sources of national surveillance data 
and population survey data concludes that an increasing 
proportion of STIs are being diagnosed in MSM who are 
diagnosed with HIV, with the population rate of STIs 
rising to four times that of HIV-negative or undiagnosed 
MSM. Moreover, STI reinfection rates were considerably 
higher in MSM who were diagnosed with HIV over a 5-year 
follow-up period. The authors believe the higher number 
of bacterial reinfections in MSM who are diagnosed with 
Table 2 Determinants of STI diagnosis in infrequently and frequently tested MSM who visited an STI clinic in the eastern 
part of the Netherlands, 2008–2013
Infrequently tested Frequently tested
Univariable 
regression analysis
OR (95% CI)
Multivariable 
analysis
OR (95% CI)
Univariable 
regression analysis
OR (95% CI)
Multivariable 
analysis
OR (95% CI)
Age (in years at baseline)
  <26 Ref NT Ref NT
  ≥26 0.8 (0.6 to 1.1) 0.9 (0.6 to 1.4)
Ethnicity (baseline)
  Dutch Ref NT Ref NT
  Non-Western 1.4 (0.8 to 2.3) 1.0 (0.5 to 1.9)
  Other Western 0.8 (0.4 to 1.7) 1.4 (0.6 to 3.2)
SES (baseline)
  Low 1.3 (0.9 to 1.7) NT 1.1 (0.7 to 1.6) NT
  Intermediate 1.2 (0.9 to 1.6) 0.8 (0.6 to 1.2)
  High Ref Ref
Mean number of partners
  <2 Ref Ref Ref Ref
  2–5 1.0 (0.7 to 1.6) 0.9 (0.6 to 1.4) 0.8 (0.5 to 1.4) 0.9 (0.5 to 1.7)
  ≥5 1.6 (1.1 to 2.4) 1.3 (0.8 to 2.0) 1.2 (0.7 to 2.1) 1.3 (0.7 to 2.4)
Notified by a partner
  Never Ref Ref Ref Ref
  Ever 2.6 (2.0 to 3.4) 2.2 (1.7 to 2.9) 2.6 (1.9 to 3.6) 2.0 (1.4 to 2.9)
STI-related symptoms
  Never Ref Ref Ref Ref
  Ever 2.0 (1.6 to 2.7) 1.6 (1.2 to 2.1) 2.6 (1.9 to 3.6) 1.8 (1.3 to 2.6)
Sexual preference
  Sex with men and women Ref Ref Ref Ref
  Sex with men 1.5 (1.1 to 2.0) 1.3 (1.0 to 1.8) 2.0 (1.4 to 2.8) 1.8 (1.2 to 2.6)
Diagnosed with HIV
  Never Ref Ref Ref Ref
  Ever 4.7 (2.8 to 7.7) 2.7 (1.5 to 4.6) 8.1 (3.7 to 17.9) 6.8 (2.6 to 17.5)
Values in bold were significant (p<0.05); due to rounding into 1 decimal, 1.0 is not always significant.
Regression analysis corrected for the number of consultations.
MSM, men who have sex with men; ref, reference; SES, socioeconomic status; STI, sexually transmitted infection; NT, not tested in 
multivariate model, since p>0.20 in univariate analysis.
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HIV are indicative of rapid transmission in dense sexual 
networks.17 An Italian study assessed risk behaviours 
before and after being diagnosed with HIV; MSM who 
are diagnosed with HIV continue to engage in at-risk 
practices: a quarter of them did not use condom during 
STI episodes, 12.5% of the participants had engaged in 
sex for money and 8.4% had paid for sex.18 Also, sero-
sorting (selecting sex partners of the same HIV status) 
or assumed serosorting among MSM who are diagnosed 
with HIV may play a role in at-risk practices. Among MSM 
who are diagnosed with HIV, the likelihood of unpro-
tected anal intercourse (UAI) is higher when a partner’s 
status was known. Furthermore, assumed seroconcordant 
UAI is associated with increased STI prevalence.19–21
By combining the results of the significant determi-
nants of frequent testing and STI diagnosis, this study 
demonstrates that MSM who had ever been notified by 
a partner and MSM who had ever had STI-related symp-
toms were more likely to have an STI diagnosis, but were 
not more likely to be frequently tested. This means that 
MSM who had symptoms or who had been notified by a 
partner appear to find their way to the STI clinics when 
necessary, but will not come back frequently. There is no 
legislation on partner notification in the Netherlands. 
Also, partner notification is performed anonymously; the 
STI clinic does not know to the full extent who is being 
notified.
We also found that MSM who were ever diagnosed with 
HIV were more often diagnosed with an STI, but did 
not visit the STI clinic more frequently than MSM who 
tested HIV-negative. Other studies also show that MSM 
who are diagnosed with HIV are more likely have an STI 
diagnosis.12–15 Routine screening for STI of MSM who 
were diagnosed with HIV is important because regular 
screening could help reduce the incidence of STI diag-
noses.22–24 MSM diagnosed with HIV are not routinely 
tested for STI in most HIV care centres, except for 
annual syphilis and hepatitis C screening. Dutch STI 
clinics put great efforts in motivating MSM to test for 
STIs by outreach activities at MSM events and providing 
anonymous online test facilities. This study highlights 
the importance of ongoing efforts done by STI clinics in 
encouraging MSM who were diagnosed with HIV to be 
tested for STI frequently.
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